A total of 75 archived formalin-fixed, paraffin-embedded (FFPE) tissue blocks of normal endometrium (10 cases), simple hyperplasia (SH, 21 cases), CAH (22 cases) and endometrial CA (22 cases) were ...

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2 We conducted a case ...

Although it might seem reasonable to pronounce women cured after their endometrial hyperplasia regresses from hormonal treatment, researchers caution that long-term monitoring for relapse and cancer ...

This page lists all known medications that could potentially lead to 'Endometrial hyperplasia' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Women with atypical endometrial hyperplasia have an increased risk of developing cancer Researchers from the University of Edinburgh have revealed that improved patient care is needed to reduce cancer ...

Endometrial hyperplasia (EH) is a condition in which the inner lining of the uterus becomes thicker and sometimes abnormal. There are different types of EH as viewed under a microscope, but the main ...

Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

Atypical endometrial hyperplasia (AEH) occurs when the lining of the uterus is too thick and contains abnormal cells. It can cause vaginal bleeding and may progress to cause further symptoms. AEH is a ...

Endometrial hyperplasia (EH) is a condition in which the uterine lining is thicker than normal. It may have many causes, but the most important association is with endometrial malignancy. For this ...

Please provide your email address to receive an email when new articles are posted on . Conjugated estrogen/bazedoxifene users had higher endometrial cancer and endometrial hyperplasia rates vs.